PUBLISHER: iData Research Inc. | PRODUCT CODE: 1396036
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1396036
The U.S. patient monitoring equipment market achieved a valuation of nearly $8.5 billion in 2023, projecting an anticipated increase throughout the forecast period at a CAGR of 4.1% to surpass $11.2 billion.
In this comprehensive medical market research, we analyzed over 140 patient monitoring companies in the U.S. Our analysis covered diverse segments, including multi-parameter vital signs monitoring, wireless ambulatory telemetry, remote patient monitoring, intracranial pressure monitoring, electromyogram (EMG) monitoring, electroencephalogram (EEG) monitoring, cerebral oximetry monitoring, fetal and neonatal monitoring, pulse oximetry monitoring, cardiac output monitoring, blood pressure monitoring, electrocardiogram (ECG) monitoring, temperature management, intraoperative neurophysiology monitoring, and capnography monitoring markets.
The dominant trend in the patient monitoring equipment market revolves around the incorporation of monitoring devices into Internet of Things (IoT) environments. This trend is underscored by robust high-single-digit growth in the remote patient monitoring market, a trajectory anticipated to persist in the forecasted period. In addition to the development of monitoring devices tailored for non-professional care settings, numerous established patient monitors are undergoing upgrades to encompass wireless connectivity and software compatibility. This enhancement aims to facilitate seamless system integration, fostering improved workflows.
In 2023, Medtronic emerged as the primary contender in the entire U.S. patient monitoring equipment market, securing a prominent position in the remote patient monitoring (RPM), cerebral oximetry, pulse oximetry, intraoperative neuromonitoring (IONM), and standalone capnography monitoring markets.
Philips Healthcare claimed the second-leading position in the U.S. patient monitoring equipment market in 2023, thanks to its active engagement in the multi-parameter vital signs, wireless ambulatory telemetry, remote patient monitoring, and fetal and neonatal monitoring markets.
GE Healthcare achieved noteworthy success across multiple segments, particularly in the multi-parameter vital signs, fetal and neonatal, electrocardiogram (ECG) monitoring, and blood pressure monitoring markets. In 2023, GE Healthcare held the third-leading position in the overall U.S. patient monitoring equipment market.
This segment is provided as an appendix only.
Regions: United States
Base Year: 2023
Forecast: 2024-2030
Historical Data: 2020-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database